Differential Gene Expression Profiles of Radioresistant Non-Small-Cell Lung Cancer Cell Lines Established by Fractionated Irradiation: Tumor Protein p53-Inducible Protein 3 Confers Sensitivity to Ionizing Radiation

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 3, 2010, Pages 858-866

  Lee, Young Sook ^a   Oh, Jung Hwa ^a   Yoon, Seokjoo ^a   Kwon, Myung Sang ^a   Song, Chang Woo ^a   Kim, Ki Hwan ^b   Cho, Moon June ^b   Mollah, Mohamad Lalmodin ^c   Je, Young Jin ^c   Kim, Yoon Dong ^c   Kim, Chang Deok ^c   Lee, Jeung Hoon ^c  

^a Korea Institute of Toxicology   (South Korea)

^b Chungnam National University   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CANDIDATE GENES; CELL LINES; CELLULAR RADIOSENSITIVITY; DIFFERENTIAL GENE EXPRESSIONS; EXPRESSION LEVELS; FRACTIONATED IRRADIATION; MICROARRAY ANALYSIS; MOLECULAR MECHANISM; MTT ASSAYS; NON SMALL CELL LUNG CANCER; OVER-EXPRESSION; RADIORESISTANCE; RIBONUCLEIC ACID;

BIOLOGICAL ORGANS; CELL CULTURE; CELL DEATH; IONIZING RADIATION; PROTEINS; RADIOTHERAPY; RNA; TUMORS;

GENE EXPRESSION;

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53; TUMOR PROTEIN; TUMOR PROTEIN P53 INDUCIBLE PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG NON SMALL CELL CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; X IRRADIATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS; RADIATION TOLERANCE;

EID: 77952563228     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.12.076     Document Type: Article

References (35)

1. Bradley J.D., Paulus R., Graham M.V., et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIa non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group-RTOG 9705. J Clin Oncol 23 (2005) 3480-3487
2. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
3. Biard D.S., Martin M., Rhun Y.L., et al. p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res 54 (1994) 3361-3364
4. O'Rourke D.M., Kao G.D., Singh N., et al. Conversion of a radioresistant phenotype to a more sensitive one by disabling erbB receptor signaling in human cancer cells. Proc Natl Acad Sci U S A 95 (1998) 10842-10847
5. Brachman D.G., Beckett M., Graves D., et al. p53 mutation dose not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 53 (1993) 3667-3669
6. Nojiri K., Iwakawa M., Ichikawa Y., et al. The proangiogenic factor ephrin-A1 is up-regulated in radioresistant murine tumor by irradiation. Exp Biol Med (Maywood) 234 (2009) 112-122
7. Ogawa K., Murayama S., and Mori M. Predicting the tumor response to radiotherapy using microarray analysis. Oncol Rep 18 (2007) 1243-1248
8. Du X.L., Jiang T., Wen Z.Q., et al. Differential expression profiling of gene response to ionizing radiation in two endometrial cancer cell lines with distinct radiosensitivities. Oncol Rep 21 (2009) 625-634
9. Fukuda K., Sakakura C., Miyagawa K., et al. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91 (2004) 1543-1550
10. Chang J.T., Chan S.H., Lin C.Y., et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 6 (2007) 2271-2279
11. Ishigami T., Uzawa K., Higo M., et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 120 (2007) 2262-2270
12. Ogawa K., Utsunomiya T., Mimori K., et al. Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation. Int J Oncol 28 (2006) 705-713
13. Xu Q.Y., Gao Y., Liu Y., et al. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J 121 (2008) 1830-1837
14. Calvano S.E., Xiao W., Richards D.R., et al. A network-based analysis of systemic inflammation in humans. Nature 437 (2005) 1032-1037
15. Lee Y.S., Sohn K.C., Jang S., et al. Anti apoptotic role of S100A8 in x-ray irradiated keratinocytes. J Dermatol Sci 51 (2008) 11-18
16. Decker P., and Muller S. Modulating poly (ADP-ribose) polymerase activity: Potential for the prevention and therapy of pathogenic situations involving DNA damage and oxidative stress. Curr Pharm Biotechnol 3 (2002) 275-283
17. Amundson S.A., Do K.T., Vinikoor L.C., et al. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res 68 (2008) 415-424
18. Sullivan F.J., Carmichael J., Glatstein E., et al. Radiation biology of lung cancer. J Cell Biochem Suppl 24 (1996) 152-159
19. Norbury C.J., and Hickson I.D. Cellular response to DNA damage. Annu Rev Pharm Toxicol 41 (2001) 367-401
20. Cardile V., Bellia M., Lombardo L., et al. Distinct response to ionizing radiation of human prostate cell lines. Oncol Rep 14 (2005) 981-985
21. Yang Y.C., Chao K.S., Lin C.P., et al. Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells. Int J Gynecol Cancer 19 (2009) 782-786
22. Prakash Sahu R., Epperly M.W., and Srivastava S.K. Benzyl isothiocyanate sensitizes human pancreatic cancer cells to radiation therapy. Front Biosci (Elite Ed) 1 (2009) 568-576
23. Zhuang H.Q., Wang J.J., Liao A.Y., et al. The biological effect of 125I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Cancer Res 28 (2009) 12
24. Liu Q., He X., Liu Y., et al. NADPH oxidase-mediated generation of reactive oxygen species: A new mechanism for X-ray-induced HeLa cell death. Biochem Biophys Res Commun 377 (2008) 775-779
25. Sasano N., Enomoto A., Hosoi Y., et al. Free radical scavenger edaravone suppresses x-ray-induced apoptosis through p53 inhibition in MOLT-4 cells. J Radiat Res (Tokyo) 48 (2007) 495-503
26. Rugo R.E., and Schiestl R.H. Increases in oxidative stress in the progeny of X-irradiated cells. Radiat Res 162 (2004) 416-425
27. Tominaga H., Kodama S., Matsuda N., et al. Involvement of reactive oxygen species (ROS) in the induction of genetic instability by radiation. J Radiat Res (Tokyo) 45 (2004) 181-188
28. Tao Y., Leteur C., Yang C., et al. Radiosensitization by Chir-124, a selective CHK1 inhibitor: Effects of p53 and cell cycle checkpoints. Cell Cycle 8 (2009) 1196-1205
29. Okaichi K., Ide-Kanematsu M., Izumi N., et al. Variations in sensitivity to ionizing radiation in relation to p53 mutation point. Anticancer Res 28 (2008) 2687-2690
30. Hill R., Bodzak E., Blough M.D., and Lee P.W. p53 Binding to the p21 promoter is dependent on the nature of DNA damage. Cell Cycle 7 (2008) 2535-2543
31. Vikhanskaya F., Lee M.K., Mazzoletti M., et al. Cancer-derived p53 mutants suppress p53-target gene expression-Potential mechanism for gain of function of mutant p53. Nucleic Acids Res 35 (2007) 2093-2104
32. Cuddihy A.R., Jalali F., Coackley C., and Bristow R.G. WTp53 induction does not override MTp53 chemoresistance and radioresistance due to gain-of-function in lung cancer cells. Mol Cancer Ther 7 (2008) 980-992
33. Yang H., Filipovic Z., Brown D., et al. Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation. Mol Cancer Ther 2 (2003) 1023-1029
34. Flatt P.M., Polyak K., Tang L.J., et al. p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest. Cancer Lett 156 (2000) 63-72
35. Pospísilová S., Siligan C., Ban J., et al. Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y. Mol Cancer Res 2 (2004) 296-304